Prifetrastat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Prifetrastat, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. [Phase 2]